Andrzejewski Dennis, Breitschwerdt Rüdiger, Fellmann Michael, Beck Eberhard
Faculty of Computer Science, University of Rostock, Albert-Einstein-Straße 22, 18059 Rostock, Germany.
Institute for eHealth and Management in Healthcare, Flensburg University of Applied Sciences, Kanzleistraße 91 - 93, 24943 Flensburg, Germany.
Health Inf Sci Syst. 2017 Oct 30;5(1):12. doi: 10.1007/s13755-017-0035-8. eCollection 2017 Dec.
Transparent decisions and its documentation of breast cancer patients' therapy are getting more important especially since modern therapeutic approaches favor personalized forms of treatment. The medical decisions for a treatment are very complex, because there are rules and different options for each patient. To support the decision process, we analyzed the current decision rules and implemented them in a prototype of a rule-based expert system. Thus, this system shall support the quality assurance regarding transparent documentation of individualized therapeutic decisions. For evaluating the system, we used data from a state tumor center and compared the decisions suggested by our system with expert ones. The system and the expert approach will be compared with each other as well as the differences in the treatment decisions. The first preliminary results show us that the human factor-like must be considered by creating a decision support system. The prototype delivers first results, which are restricted, but the results are promising for further developments.
透明决策及其对乳腺癌患者治疗的记录变得越来越重要,特别是因为现代治疗方法倾向于个性化的治疗形式。治疗的医学决策非常复杂,因为针对每个患者都有规则和不同的选择。为了支持决策过程,我们分析了当前的决策规则并将其应用于基于规则的专家系统原型中。因此,该系统应支持关于个性化治疗决策透明记录的质量保证。为了评估该系统,我们使用了一个州立肿瘤中心的数据,并将我们系统建议的决策与专家决策进行了比较。该系统和专家方法将相互比较,以及治疗决策中的差异。初步结果表明,在创建决策支持系统时必须考虑人为因素。该原型提供了初步结果,虽然有限,但结果对进一步发展很有希望。